DNLI
Denali Therapeutics Inc.
There isn't enough reported data to score DNLI yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
DNLI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Strong |
DNLI's balance sheet is currently strong, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
DNLI PE Valuation
DNLI has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
DNLI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect DNLI's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
DNLI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.73 | +$1.18 |
| Q2 2026 | -$2.84 | -$0.04 |
| Q1 2026 | -$2.88 | -$0.21 |
| Q4 2025 | -$2.97 | -$0.40 |
| Q3 2025 | -$2.91 | -$0.17 |
| Q2 2025 | -$2.80 | +$0.03 |
| Q1 2025 | -$2.67 | -$1.73 |
| Q4 2024 | -$2.57 | -$1.51 |
DNLI lost $1.73 per share over the past year, a smaller loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over DNLI on earnings quality, reporting a profit while its opponent remains loss making.
DNLI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2023 | $1.3M | -64% |
| Q2 2023 | $294.1M | +460% |
| Q1 2023 | $35.1M | -17% |
| Q4 2022 | $10.3M | -18% |
| Q3 2022 | $3.6M | -33% |
| Q2 2022 | $52.5M | +129% |
| Q1 2022 | $42.1M | +432% |
| Q4 2021 | $12.5M | -96% |
DNLI's revenue is growing: $18M last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -713% | N/A |
| Q2 2026 | -3622% | N/A |
| Q3 2023 | -8981% | -5961 points |
| Q2 2023 | 58% | +175 points |
| Q1 2023 | -344% | -186 points |
| Q4 2022 | -1024% | -408 points |
| Q3 2022 | -3020% | -1401 points |
| Q2 2022 | -117% | +153 points |
DNLI's operating margin was −713% last quarter, down 369 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over DNLI on profitability, with a higher operating margin.
DNLI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$118.5M | -$12.5M |
| Q2 2026 | -$97.8M | -$18.2M |
| Q1 2026 | -$133.7M | +$2.9M |
| Q4 2025 | -$100.1M | -$11.3M |
| Q3 2025 | -$105.9M | -$42.9M |
| Q2 2025 | -$79.6M | +$16.4M |
| Q1 2025 | -$136.5M | -$20.8M |
| Q4 2024 | -$88.8M | +$12.1M |
DNLI has burned cash in almost every quarter: −$450M over the past year, against −$411M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over DNLI on cash generation, producing positive trailing cash flow while its opponent burns cash.
DNLI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +4.8M shares |
| 1 year | +11% | +19.7M shares |
| 3 years | +40% | +54.4M shares |
| 5 years | +58% | +70.3M shares |
| Available history | +100% | +96M shares |
DNLI has 192M diluted shares, up 11% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over DNLI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
DNLI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | -11.6x | Net Cash |
| Q2 2021 | -8.2x | Net Cash |
| Q1 2021 | -7.3x | Net Cash |
| Q4 2020 | -7.1x | Net Cash |
DNLI has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
DNLI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.5 | Neutral |
| Stochastic | 23.4 | Neutral |
DNLI's weekly RSI is 44 (neutral) and its Stochastic is 23 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
DNLI PE vs Healthcare Sector
| Metric | DNLI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
DNLI has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
DNLI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.2 | 1.7% below |
| 20 week MA | $21.8 | 13% below |
| 50 week MA | $20.6 | 8.1% below |
| 100 week MA | $18.4 | 2.9% above |
| 200 week MA | $21.0 | 9.8% below |
DNLI's trend is mixed: it's above one of its five weekly moving averages, and 9.8% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over DNLI on trend strength, trading above more of its moving averages.
DNLI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.3 | $85.9 | +370% |
| 2021 | $85.9 | $47.5 | -45% |
| 2022 | $47.5 | $27.9 | -41% |
| 2023 | $27.9 | $21.5 | -23% |
| 2024 | $21.5 | $20.6 | -4% |
| 2025 | $20.6 | $16.9 | -18% |
| 2026 YTD | $16.9 | $18.9 | +12% |
DNLI has finished five years in a row lower, and it's up 12% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over DNLI on returns for 2026, with the stronger performance.